Abstract:Individual depressive theories founded on neurobiological information are examined because they hold great relevance to both clinical investigators seeking to create innovative treatments for depression and physicians in everyday practice. One such theory is the proposition that the main underlying issue behind depressive disorders is a deficiency in central monoaminergic function. This theory highlights the importance of addressing the role of neurotransmitters such as glutamate, gamma-aminobutyric acid (GABA), norepinephrine, serotonin, and dopamine, as well as factors like neurocircuitry, neurotrophic factors, and the rhythm of the circadian clock. Major depressive disorder, a severe condition with significant societal and therapeutic implications, necessitates tailored antidepressant treatments. These treatments encompass both pharmacological interventions and emotional therapies, all of which need to be customized based on specific patients and medical circumstances. The understanding of depression is complex and constantly evolving, with various explanations and theories applying only to specific types of depressed individuals while disregarding others. Furthermore, the pathogenesis of depression can undergo significant changes during the disease’s development. This dynamic nature challenges the notion that depression can be characterized by a single hypothesis or theory. Thus, the extensive body of available research highlights the need for a comprehensive approach that incorporates multiple concepts and factors when studying and treating depression. By considering the intricate interplay of various neurobiological elements and personal circumstances, researchers and medical professionals can strive to provide more effective and tailored interventions for individuals suffering from depression.

Advanced in Search for Central Neurotransmitters and Treatment Involved in Depression

[Progress of Monoaminergic Receptor Investigation on Depression].

Advances in Novel MolecularTargets for Antidepressants

Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression

Neurobiochemical and Neuroelectrophysiologic Studies of Depression

Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications

Research Advances on Mechanisms of Depression

Research progress on the analytical methods of biochemicals relevant to depression

Clinical and Pathogenesis Researches on Depressive Disorder in China

Advanced research in tryptophan-kynurenine pathway and its metabolites in depression

Pathogenesis of depression and the mechanism research in TCM treatment of major depression

Advances in antidepressants and research methods of depression

Research progress of neurobiochemical mechanism of depression

Research on Pathological Mechanism of Depression and Antidepressant Drug Target

Research status of neuro-immunological targets in pathogenesis of depression

New advances in therapeutic targets for antidepressants

Clinical Translation of Neuroimaging Research in Depression: A New Approach to Prevention, Diagnosis and Treatment of Depression

Research Progress on Neural Circuit Mechanisms of Depression

Progress of research on the treatment of depression by traditional Chinese medicine prescriptions

Pathogenesis of depression and the potential for traditional Chinese medicine treatment

Neurobiological Investigation of Depression: Unraveling the Biological Basis of a Complex Mental Health Challenge